KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Acquisitions: 2019

Historic Acquisitions for Sarepta Therapeutics (SRPT) over the last 1 years, with Dec 2019 value amounting to $172.6 million.

  • Sarepta Therapeutics' Acquisitions was N/A to $2.4 million in Q1 2014 from the same period last year, while for Mar 2014 it was $9.6 million, marking a year-over-year change of. This contributed to the annual value of $172.6 million for FY2019, which is N/A change from last year.
  • Latest data reveals that Sarepta Therapeutics reported Acquisitions of $172.6 million as of FY2019.
  • Over the past 5 years, Sarepta Therapeutics' Acquisitions peaked at $172.6 million during FY2019, and registered a low of $172.6 million during FY2019.
  • For the 1-year period, Sarepta Therapeutics' Acquisitions averaged around $172.6 million, with its median value being $172.6 million (2019).